Bright Minds Biosciences Net Debt Growth & History (DRUG)
Bright Minds Biosciences's net debt was −$82.8M for fiscal 2025.
View full Bright Minds Biosciences company overviewBright Minds Biosciences annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | −$82.8M | −$77.2M | — |
| 2024 | 2024-09-30 | −$5.6M | $1.1M | — |
| 2023 | 2023-09-30 | −$6.7M | $4.8M | — |
| 2022 | 2022-09-30 | −$11.5M | $8.3M | — |
| 2021 | 2021-09-30 | −$19.8M | — | — |
Bright Minds Biosciences quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | −$307.8M | −$256.5M | — |
| Q2 2026 | 2026-03-31 | −$309.6M | −$254.1M | — |
| Q1 2026 | 2025-12-31 | −$88.9M | — | — |
| Q4 2025 | 2025-09-30 | −$82.8M | −$77.2M | — |
| Q3 2025 | 2025-06-30 | −$51.2M | — | — |
| Q2 2025 | 2025-03-31 | −$55.5M | — | — |
| Q4 2024 | 2024-09-30 | −$5.6M | $1.1M | — |
| Q4 2023 | 2023-09-30 | −$6.7M | $4.8M | — |
| Q4 2022 | 2022-09-30 | −$11.5M | $8.3M | — |
| Q4 2021 | 2021-09-30 | −$19.8M | — | — |
Bright Minds Biosciences net debt trends
Between the periods ended 2021-09-30 and 2025-09-30, Bright Minds Biosciences's net debt decreased from −$19.8M to −$82.8M, a change of −$63.0M. The latest reported quarter, Q3 2026, shows −$307.8M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bright Minds Biosciences source filings ↗